Voya Investment Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

A detailed history of Voya Investment Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 289,699 shares of ARWR stock, worth $5.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
289,699
Previous 266,062 8.88%
Holding current value
$5.37 Million
Previous $6.91 Million 18.89%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.36 - $29.54 $457,612 - $698,236
23,637 Added 8.88%
289,699 $5.61 Million
Q2 2024

Aug 14, 2024
BUY
$21.87 - $28.24 $1.84 Million - $2.38 Million
84,174 Added 46.28%
266,062 $6.91 Million
Q1 2024

May 15, 2024
SELL
$27.21 - $39.48 $162,879 - $236,327
-5,986 Reduced 3.19%
181,888 $5.2 Million
Q4 2023

Feb 14, 2024
BUY
$21.2 - $31.03 $168,010 - $245,912
7,925 Added 4.4%
187,874 $5.75 Million
Q3 2023

Nov 14, 2023
SELL
$26.2 - $36.08 $1.1 Million - $1.52 Million
-42,022 Reduced 18.93%
179,949 $4.84 Million
Q2 2023

Aug 14, 2023
SELL
$25.16 - $41.38 $214,790 - $353,261
-8,537 Reduced 3.7%
221,971 $7.92 Million
Q1 2023

May 15, 2023
SELL
$23.68 - $38.51 $625,270 - $1.02 Million
-26,405 Reduced 10.28%
230,508 $5.85 Million
Q4 2022

Feb 14, 2023
BUY
$28.0 - $40.56 $130,340 - $188,806
4,655 Added 1.85%
256,913 $10.4 Million
Q3 2022

Mar 03, 2023
SELL
$29.63 - $48.31 $137,927 - $224,883
-4,655 Reduced 1.81%
252,258 $8.34 Million
Q3 2022

Nov 14, 2022
BUY
$29.63 - $48.31 $715,475 - $1.17 Million
24,147 Added 10.59%
252,258 $8.34 Million
Q2 2022

Aug 15, 2022
BUY
$27.79 - $50.61 $2.17 Million - $3.95 Million
77,979 Added 51.94%
228,111 $8.03 Million
Q1 2022

May 16, 2022
BUY
$39.62 - $69.97 $1.73 Million - $3.06 Million
43,783 Added 41.17%
150,132 $6.91 Million
Q4 2021

Feb 14, 2022
SELL
$58.09 - $82.51 $9.41 Million - $13.4 Million
-161,964 Reduced 60.36%
106,349 $7.05 Million
Q3 2021

Nov 15, 2021
BUY
$58.38 - $84.96 $5,721 - $8,326
98 Added 0.04%
268,313 $16.8 Million
Q2 2021

Aug 16, 2021
SELL
$62.15 - $90.32 $768,484 - $1.12 Million
-12,365 Reduced 4.41%
268,215 $22.2 Million
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $930,495 - $1.37 Million
-15,167 Reduced 5.13%
280,580 $18.6 Million
Q4 2020

Feb 16, 2021
SELL
$43.82 - $85.37 $2.84 Million - $5.52 Million
-64,712 Reduced 17.95%
295,747 $22.7 Million
Q3 2020

Nov 16, 2020
SELL
$33.21 - $51.27 $370,357 - $571,763
-11,152 Reduced 3.0%
360,459 $15.5 Million
Q2 2020

Aug 14, 2020
SELL
$26.12 - $43.27 $2.65 Million - $4.38 Million
-101,322 Reduced 21.42%
371,611 $16 Million
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $808,336 - $2.48 Million
39,316 Added 9.07%
472,933 $13.6 Million
Q4 2019

Feb 14, 2020
BUY
$28.14 - $73.01 $10.5 Million - $27.2 Million
373,124 Added 616.81%
433,617 $27.5 Million
Q3 2019

Nov 14, 2019
SELL
$26.26 - $34.86 $4,936 - $6,553
-188 Reduced 0.31%
60,493 $1.71 Million
Q2 2019

Aug 14, 2019
BUY
$17.43 - $28.82 $409,064 - $676,376
23,469 Added 63.07%
60,681 $1.61 Million
Q1 2019

May 15, 2019
BUY
$12.05 - $20.18 $12,809 - $21,451
1,063 Added 2.94%
37,212 $683,000
Q4 2018

Feb 14, 2019
BUY
$10.74 - $19.7 $23,101 - $42,374
2,151 Added 6.33%
36,149 $449,000
Q2 2018

Aug 14, 2018
BUY
$6.37 - $14.02 $216,567 - $476,651
33,998 New
33,998 $462,000

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
91.1M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email